The RNA splicing factor HNRNPL is involved in the repression or activation of exon inclusion in targeted genes, and its high expression consistently correlated with unfavorable prognosis in renal cancer (p < 0.001), liver cancer (p < 0.001), and pancreatic cancer (p < 0.001). Here, HNRNPL is linked to renal carcinoma.